CCR5 blockade for neuroinflammatory diseases — beyond control of HIV | Nature Reviews Neurology
CRISPR-Cas9-mediated gene disruption of HIV-1 co-receptors confers broad resistance to infection in human T cells and humanized mice: Molecular Therapy - Methods & Clinical Development
The Strategies and Challenges of CCR5 Gene Editing in Hematopoietic Stem and Progenitor Cells for the Treatment of HIV | SpringerLink
CCR5-edited gene therapies for HIV cure: Closing the door to viral entry - Cytotherapy
HEK293T Cells Are Heterozygous for CCR5 Delta 32 Mutation | PLOS ONE
Prevalence of CCR5delta32 in Northeastern Iran | BMC Medical Genetics | Full Text
CCR5-edited gene therapies for HIV cure: Closing the door to viral entry - ScienceDirect
CCR5-delta 32 Gene Transplant: Permanent cure of HIV - Civilsdaily
GeneCopoeia: CCR5 Signaling Pathway
CCR5, Delta-32 Mutation and the HIV Infection Pathway - microbewiki
CRISPR/Cas9-Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo: Molecular Therapy
CCR5 and its ligands: a new axis of evil? | Nature Immunology
CCR5 Disruption in Induced Pluripotent Stem Cells Using CRISPR/Cas9 Provides Selective Resistance of Immune Cells to CCR5-tropic HIV-1 Virus: Molecular Therapy - Nucleic Acids
BioTech | Free Full-Text | Closing the Door with CRISPR: Genome Editing of CCR5 and CXCR4 as a Potential Curative Solution for HIV
CCR5 - Wikipedia
The potential risks of C-C chemokine receptor 5-edited babies in bone development | Bone Research
Viruses | Free Full-Text | CCR5: From Natural Resistance to a New Anti-HIV Strategy
Structure of the CCR5-893() gene product. Outlined letters in gray... | Download Scientific Diagram